Category Specific RSS

living cell technologies

Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases

As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is…

2 years ago

Algorae debuts new name with AI modelling partnership with the UNSW

In a promising new chapter, Algorae Pharmaceuticals (ASX: 1AI), formerly known as Living Cell Technologies (ASX: LCT), has debuted its…

2 years ago

Living Cell Technologies latest project targets dementia with cannabinoid-based drug

As of 2022, Australia is witnessing nearly 400,000 individuals grappling with dementia. Dementia is the second leading cause of death…

2 years ago

Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease

Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote…

4 years ago